Clinical trial No longer in our active list Interventional Ages 18 and up

Using a special dressing to reduce surgical site infections in vascular surgery

Official title: A Randomised Controlled Trial to Assess the Clinical and Cost Effectiveness of Dialkylcarbamoylchloride (DACC) Coated Post-operative Dressings Versus Standard Care in the Prevention of Surgical Site Infection in Clean or Clean-contaminated, Vascular Surgery.

Run by Hull University Teaching Hospitals NHS Trust · NCT02992951 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing a special dressing made from spider silk to see if it can help prevent infections after lower limb vascular surgery compared to regular dressings.

More Infection, Bacterial trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment718 (estimated)
SponsorHull University Teaching Hospitals NHS Trust
Government
Locations1 site (Hull, East Riding Of Yorkshire)
Trial IDNCT02992951 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older undergoing clean or clean-contaminated lower limb vascular surgery.

Probably not a fit

Patients undergoing procedures that do not involve lower limb incisions or those on antibiotics for other conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial investigates the effectiveness of a DACC-coated dressing, derived from spider silk, in reducing surgical site infections compared to standard non-coated dressings in patients undergoing lower limb vascular surgery. The study will recruit 718 adult patients across multiple centers in the UK, focusing on those with clean or clean-contaminated wounds closed by primary intention. Participants will be monitored for infection rates post-surgery to assess the dressing's performance. The goal is to provide a cost-effective solution to a significant problem in surgical care.

Why it matters

Potential benefit: If successful, this dressing could significantly reduce the incidence of surgical site infections, improving patient outcomes and reducing healthcare costs.

How similar studies have gone: While the use of DACC-coated dressings is innovative, similar approaches in infection control have shown promise, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

In order to be eligible for inclusion in the study the participants must meet the following criteria:

* Adults ≥18 yrs undergoing clean or clean-contaminated lower limb vascular surgery, with wounds closed by primary intention.
* Able to understand the Patient Information Sheet and supplementary materials and capable and willing to give informed consent and follow the protocol requirements (including attending all follow-up visits and completing written questionnaires).

Exclusion Criteria:

Patients will not be included in the study if they meet any of the following exclusion criteria:

* Patients on antibiotics for other conditions at the time of surgery or in the follow up period.
* Patients undergoing any procedure that does not include lower limb incisions.
* Allergies to any component of either the DACC-coated dressing or the control dressing.
* Inability to give informed consent due to incapacity (as defined by the MCA 2005)
* Aged under 18 years at the time of recruitment
* Use of investigational drug/device therapy within preceding 4 weeks that may interfere with this study.

Where it's running

  • Academic Vascular Surgery Unit, Vascular Laboratory, Alderson House, Hull Royal Infirmary
    Hull, East Riding Of Yorkshire, United Kingdom
    Recruiting

Study contacts

  • Principal investigator: George Smith, M.D — Hull University Teaching Hospitals NHS Trust
  • Study coordinator: Ross Lathan, MBChB
  • Email: ross.lathan2@nhs.net
  • Phone: +44 01482674643

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.